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Background   Hydroxyapatite (HA) is the main inorganic compo-
nent of bone, and HA coating is widely used on acetabular cups 
in hip arthroplasty. It has been suggested that this surface finish 
improves cup survival.
Methods   All patients registered in the Swedish Hip Arthroplasty 
Register between 1992 and 2007 with an uncemented acetabular 
implant that was available either with or without HA coating 
were identified. 8,043 total hip arthroplasties (THAs) with the 
most common cup types (Harris-Galante, Romanus, and Trilogy) 
were investigated. A Cox regression model including type of coat-
ing, age, sex, primary diagnosis, cup type, and type of stem fixa-
tion was used to calculate adjusted risk ratios (RRs) for the risk 
of revision.
Results   HA coating was a risk factor for cup revision due to 
aseptic loosening (adjusted RR 1.7; 95% CI: 1.3–2). Age at pri-
mary arthroplasty of < 50 years, a diagnosis of pediatric hip dis-
ease, the use of a cemented stem, and the Romanus and Harris-
Galante cup types were also associated with statistically signifi-
cantly increased risk of cup revision due to aseptic loosening.
Interpretation   Our findings question the routine use of HA-
coated cups in primary total hip arthroplasty. With some designs, 
this practice may even increase the risk of loosening—resulting in 
revision surgery. 

Hydroxyapatite  (HA)  is  the  main  inorganic  component  of 
human  bone.  It  was  therefore  hypothesized  early  on  that 
coating of metallic implants with HA would enhance bone 
ingrowth and thus lead to better initial or even long-term sta-
bility. There was experimental evidence that HA was in fact 
well tolerated by the organism without leading to foreign body 
reactions (Nery et al. 1975), that HA coating enhanced bone 
ingrowth (Jarcho et al. 1977), and that implants coated with 
HA  showed  improved  fixation  to  surrounding  bone  tissue 
(Ducheyne et al. 1980).
Based on these findings, HA coating was applied to ace-
tabular and femoral arthroplasty components. Initial reports 
on acetabular cups coated with HA suggested reduced rota-
tional  cup  migration  and  reduced  incidence  of  radiolucent 
lines (Moilanen et al. 1996), with few revisions after short- 
or medium-term follow-up (Roffman and Kligman 1999, Ali 
and Kumar 2003). On the other hand, several publications on 
cohorts of less than 200 patients described high failure rates 
of various cups coated with HA (Reikeras and Gunderson 
2002, Lai et al. 2002, Miyakawa et al. 2004, Cheung et al. 
2005, Kim et al. 2006), sometimes due to severe osteolysis 
and third-body wear secondary to abrasion of HA particles 
(Morscher et al. 1998).
Despite the fact that it is unclear whether HA coating is ben-
eficial to acetabular implant survival, the orthopedic implant 
industry nowadays provides a vast array of cups and stems that 
have been coated with HA. Moreover, these implants are more 
expensive than those without such coating. Thus, the ques-
tion of whether HA coating is beneficial is both medically and 
economically relevant.
We analyzed patient data on uncemented cups with or with-
out HA coating that had been recorded in the Swedish Hip 
Arthroplasty Register. Our hypothesis was that coating of ace-
tabular cups with HA would influence the risk of cup revision 
due to aseptic loosening and osteolysis. Our primary endpoint 
was revision due to aseptic loosening, which in the Swedish 
Hip Arthroplasty register also includes osteolysis. Secondary 
endpoints were cup revision for any reason, and cup revision 
due to infection.54  Acta Orthopaedica 2010; 81 (1): 53–59
Patients and methods
Sources of data
Data were extracted from the Swedish Hip Arthroplasty Reg-
ister.  Every  Swedish  citizen  has  a  personal  identification 
(social security) number that is linked to information on all 
changes relevant to the follow-up, such as change of address, 
date of emigration, or the date of death. All orthopedic units 
in Sweden that perform total hip arthroplasty, both public and 
private, report to the register. Revisions have been registered 
since 1979. All reoperations (any secondary operation of the 
hip) and revisions (exchange or removal of any of the com-
ponents) are continuously reported by all operating units in 
Sweden.  The  Swedish  Hip Arthroplasty  Register  has  been 
repeatedly validated (Söderman et al. 2000, 2001).
Since 1979, over 270,000 primary total hip replacements 
and 32,000 revisions have been recorded. Until 1991, data 
were aggregated in terms of hospital and were not linked to 
the personal ID number. In 1992 this was changed, which 
enabled  more  detailed  and  reliable  studies  of  individual 
implant designs, as in this study. This recording also included 
whether or not there was HA coating. Some frequently used 
cups initially only available without HA coating were later 
modified to also embrace a version with HA coating added 
on to the surface of the original cup. This enables comparative 
retrospective analyses of components with identical design 
apart from their surface finish.
Study population
All primary total hip arthroplasties (THAs) registered in the 
Swedish Hip Arthroplasty Register between 1992 and 2007 
using an uncemented cup that was available with or without 
HA coating were identified (8,705 hips). There were 5 such 
cup designs: Trilogy (n = 5,536 hips), Romanus (n = 1,531), 
Harris-Galante II (n = 976), Reflection (n = 437), and Biomex 
(n = 225). To reduce the risk of bias caused by patient selec-
tion, surgical preference and technique, and other factors not 
recorded in the register, only acetabular implants with 500 
or more registered hips per implant were included (Trilogy, 
Romanus, and Harris-Galante). This left a study population of 
6,646 patients with 8,043 THAs (Tables 1 and 2).
The Trilogy (Zimmer Inc., Warsaw, IN) and Harris-Galante 
II (also Zimmer) cups are hemispherical press-fit shells. The 
Romanus cup is hemispherical and threaded (Biomet, Warsaw, 
IN). All 3 designs are made of titanium alloy supplied with 
a porous coating made of commercially pure titanium. All 
implants  were  available  with  or  without  HA  coating.  The 
ceramic coating on the Harris-Galante II and Trilogy cups con-
sists of a mixture of HA (70%) and tricalcium phosphate (TCP, 
30%), whereas the Romanus cup is coated with 60% HA and 
40% TCP. Different types of cemented and uncemented stems 
were combined with these cups, creating hybrid and totally 
uncemented systems (Table 3). The material of the femoral 
heads was not recorded and there was no reliable recording 
of head diameter, which precluded any statistical analysis of 
these parameters. 
Statistics
Follow-up started on the day of primary THA and ended on 
the day of revision, death, emigration, or December 31, 2007, 
whichever came first. 
A Cox proportional hazards model was applied in order 
to analyze the relative risk (RR) of revision (with 95% con-
fidence  intervals  (CIs))  due  to  aseptic  loosening,  revision 
Table 2. Acetabular components in the hips studied
    + HA  – HA  Total
   n   %   n   % 
Trilogy   4,501    86   1,035    37   5,536
Romanus   440    9   1,091    38   1,531
Harris-Galante   272    5   704    25   976
Total   5,213    100   2,830    100   8,043
Table 1. Characteristics of the patients studied (n = 6,646) 
from the Swedish Hip Arthroplasty Register (1992–2007)
   n    %
Sex 
  Male  3,367  51
  Female  3,279      49
Age (years) 
  0–49  1,705      26
     50–59  2,614      39
     60–75  2,142      32
     > 75  185         3
Primary diagnosis 
    Primary OA  5,037      77
    Inflammatory disease  324         5
    Fracture  257         4
    Pediatric hip disease  599         9
    Idiopathic femoral head necrosis  210        3
    Secondary posttraumatic OA  37          0.6
    Tumor  7            0.1
    Other  50          0.8
Total  6,646  100
Table 3. Distribution of cemented and uncemented stems
Uncemented cups:  + HA  – HA  Total
  n   %   n   %   n   %
Cemented stem  2,919   56   1,495   53   4,414    55
Uncemented stem  2,287   44   1,331   47   3,618    45Acta Orthopaedica 2010; 81 (1): 53–59  55
due to infection, or for any reason, mutually adjusted for rel-
evant covariates: absence or presence of HA coating, sex, age 
(< 50, 50–59, 60–75, > 75 years), primary diagnosis before 
arthroplasty (primary osteoarthritis (OA), inflammatory dis-
ease (e.g. rheumatoid arthritis, morbus Bechterew), femoral 
neck fracture, pediatric hip disease, idiopathic femoral head 
necrosis, secondary posttraumatic OA, tumor, and other diag-
noses), cup design (Harris-Galante, Romanus, Trilogy), and 
type of stem fixation (cemented or uncemented). The assump-
tion of proportional hazards was investigated by hazard func-
tion plots and log-log plots of all covariates. No sign of insuf-
ficient proportionality was detected in the hazard functions, 
and log-log plots ran strictly parallel for all covariates. It has 
been pointed out that the inclusion of both joints in bilaterally 
operated patients can create dependency problems (Ranstam 
2002), and we therefore investigated whether our Cox regres-
sion model was robust against this potential violation. Sepa-
rate analyses were made, either after including all joints (8,043 
hips in 6,646 individuals) or after excluding the second side in 
bilaterally operated patients (6,646 hips in 6,646 individuals). 
The calculated crude and adjusted risk ratios were not affected 
by the inclusion of both THAs of bilaterally operated patients 
(supplementary Tables 4 and 5 describe the results after exclu-
sion of the second side in bilaterally operated patients; see 
supplementary data). In addition, in a separate analysis the 
variable “first or second operated side” was entered as a time-
dependent covariate in a Cox regression model including all 
other covariates mentioned above. Again, this procedure did 
not affect the results. Moreover, previous authors have shown 
that inclusion of both sides in bilaterally operated patients 
in Cox regression models is feasible (Lie et al. 2004, Thil-
lemann et al. 2008). We therefore included all 8,043 THA in 
our study.
An initial analysis was performed in which all covariates 
mentioned above were entered as singular variables, and a 
crude risk ratio was calculated for each variable. Thereafter, 
all of these covariates were entered in the regression model 
and risk ratios were mutually adjusted for all covariates. Crude 
and adjusted risk ratios were calculated both for revision due 
to aseptic loosening and for revision for any reason. All statis-
tical analyses were performed using SPSS (version 16.0).
Table 4. Relative risk (RR) of cup revision due to aseptic loosening. 8,043 hips in 6,646 patients. 
Endpoint: aseptic loosening   No. of    No. of     Crude RR  Adjusted RR 
  patients  revisions  (95% CI)     (95% CI)
Coating    
  – HA  2,830  257  1.0 (ref) a  1.0 (ref)
   + HA   5,213   180   1.12 (0.98–1.46)   1.65 (1.32–2.06)
Sex    
  Female  4,048  232  1.0 (ref)  1.0 (ref)
  Male   3,995   205   1.10 (0.91–1.33)   1.06 (0.87–1.28)
Primary diagnosis    
   Primary OA  6,152  309  1.0 (ref)  1.0 (ref)
   Inflammatory disease  421  34  1.19 (0.83–1.69)  0.80 (0.55–1.15)
  Fracture  266  7  0.84 (0.40–1.78)  0.71 (0.34–1.51)   
  Pediatric hip disease  722  53  1.96 (1.47–2.63)  1.57 (1.15–2.13)
  Idiopathic femoral head necrosis  249  13  1.23 (0.71–2.14)  1.06 (0.61–1.86)
  Secondary posttraumatic OA  39  5  1.83 (0.76–4.43)  1.40 (0.57–3.41)
   Tumor  7  0  0.00 (0.00–∞)  0.00 (0.00–∞)
   Other   52  8   1.13 (0.56–2.28)   0.90 (0.44–1.82)
Age    
   0–49  1,992  179  1.0 (ref)   1.0 (ref)
   50–59  3,147  173  0.59 (0.48–0.73)  0.59 (0.47–0.74)
   60–75  2,677  82  0.42 (0.32–0.54)  0.42 (0.31–0.56)
   > 75  227   3  0.54 (0.17–1.69)  0.61 (0.19–1.92)
Cup design    
   Trilogy  5,536  70  1.0 (ref)  1.0 (ref)
   Romanus  1,531  213  1.93 (1.45–2.56)  2.62 (1.90–3.63)
  Harris-Galante   976  154   1.86 (1.37–2.51)   2.44 (1.77–3.37)
Stem fixation    
  Cemented stem   4,414  290  1.0 (ref)  1.0 (ref) 
  Uncemented stem   3,618  147   1.11 (0.91–1.35)  0.76 (0.61–0.95)
  
a ref: reference group.
A Cox regression analysis was performed where covariates (age, sex, primary diagnosis, HA coating, 
cup design, and stem fixation) were initially entered as singular variables, and a crude risk ratio was 
calculated for each variable. Thereafter, all covariates mentioned above were entered in the regression 
model and risk ratios were mutually adjusted for all covariates. Crude and adjusted risk ratios (RRs) 
were calculated for revision due to aseptic loosening.
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Results
Characteristics of the study population
The numbers of males and females were about equal. The 
largest number of THAs was found in the age groups between 
50 and 75 years. Primary osteoarthritis was the most common 
preoperative diagnosis. The group with HA-coated cups was 
larger than the group with uncoated cups. By 2007, 685 (8.5%) 
of all 8,043 cups had been revised, mostly due to aseptic loos-
ening (5.7%), dislocation (1.0%), or deep infection (0.8%).
Risk of cup revision due to aseptic loosening
The crude risk ratio of HA coating for the risk of revision for 
aseptic cup loosening was 1.1 (95% CI: 0.98–1.5) without 
adjusting for covariates (Table 4). In the next step, the risk 
of revision due to aseptic cup loosening including all factors 
mentioned above as covariates was analyzed, and risk ratios 
of each covariate mutually adjusted for all other factors were 
calculated. We found that HA coating was a risk factor for 
cup revision due to aseptic loosening with an adjusted risk 
ratio of 1.7 (95% CI: 1.3–2.1). In this analysis age at primary 
arthroplasty of below 50 years, a diagnosis of previous pedi-
atric hip disease, and the presence of Romanus or Harris-
Galante cups were also associated with statistically significant 
increased risk of cup revision due to aseptic loosening. Use of 
a cemented stem was another risk factor (Table 4).
The type of hospital at primary arthroplasty was included 
in the Cox regression model, but was found not to statistically 
significantly influence the adjusted risk ratios of the covariates 
mentioned above (data not shown).
Risk of cup revision for any reason
The crude risk ratio of HA coating for the risk of cup revi-
sion for any reason without adjustment for covariates was 1.1 
(95% CI: 0.93–1.3) (Table 5). Subsequently, risk ratios of each 
covariate mutually adjusted for all other factors were calcu-
lated. The results were similar to those found in the analysis for 
the risk of revision due to aseptic loosening: HA coating was 
a risk factor for cup revision for any reason, with an adjusted 
risk ratio of 1.4 (95% CI: 1.2–1.8). The covariates age at pri-
mary arthroplasty below 50 years, the use of a cemented stem, 
and the presence of Romanus or Harris-Galant cups statisti-
Table 5. Relative risk (RR) of cup revision for any reason. 8,043 hips in 6,646 patients. 
Endpoint: any reason  No. of    No. of     Crude RR  Adjusted RR
  patients   revisions  (95% CI)   (95% CI)  
Coating    
  – HA  2,830  331  1.0 (ref) a  1.0 (ref)
  + HA   5,213   245   1.11 (0.93–1.32)   1.44 (1.18–1.75)
Sex    
   Female  4,048  265  1.0 (ref)  1.0 (ref)
   Male   3,995  311  1.14 (0.97–1.35)  1.12 (0.94–1.32) 
Primary diagnosis    
   Primary OA  6,152  410  1.0 (ref)  1.0 (ref)
   Inflammatory disease  421  42  1.13 (0.83–1.56)  0.80 (0.57–1.11)
  Fracture  266  12  1.03 (0.58–1.83)  0.91 (0.51–1.62)
   Pediatric hip disease  722  65  1.75 (1.34–2.27)  1.42 (1.08–1.87)
   Idiopathic femoral head necrosis  249  17  1.19 (0.73–1.93)  1.06 (0.65–1.73)
   Secondary posttraumatic OA  39  8  2.28 (1.13–4.59)  1.78 (0.87–3.61)
   Tumor  7  1  6.29 (0.88–∞)  4.77 (0.67–∞)
   Other   52   10  1.14 (0.61–2.14)  0.93 (0.50–1.76)
Age    
   0–49  1,992  222  1.0 (ref)  1.0 (ref)
   50–59  3,147  232  0.64 (0.53–0.77)  0.65 (0.53–0.79)
   60–75  2,677  117  0.47 (0.38–0.59)  0.47 (0.37–0.60)
   > 75   227  5   0.58 (0.24–1.41)  0.64 (0.26–1.57) 
Cup design    
   Trilogy  5,536  123  1.0 (ref)  1.0 (ref)
   Romanus  1,531  254  1.69 (1.34–2.13)  2.04 (1.57–3.66)
   Harris-Galante   976  199  1.78 (1.39–2.28)   2.16 (1.66–2.82)  
Stem fixation    
   Cemented stem   4,414   377  1.0 (ref)  1.0 (ref)
   Uncemented stem  3,618   199  1.09 (0.92–1.29)  0.84 (0.69–1.02)
a ref: reference group.
A Cox regression analysis was performed where covariates (age, sex, primary diagnosis, HA 
coating, cup design, and stem fixation) were initially entered as singular variables, and a crude risk 
ratio was calculated for each variable. Thereafter, all covariates mentioned above were entered in 
the regression model and risk ratios were mutually adjusted for all covariates. Crude and adjusted 
risk ratios (RRs) were calculated for revision for any reason.Acta Orthopaedica 2010; 81 (1): 53–59  57
cally significantly increased the risk of cup revision for any 
reason (Table 5).
The risk of revision due to infection was not influenced by 
the presence of an HA coating (data not shown).
Discussion
Our  analysis  indicates  that  HA  coating  of  acetabular  cups 
influences the outcome. However, contrary to the results of 
some  previous  studies  and  a  commonly  expressed  opin-
ion (Moilanen et al. 1996, Roffman and Kligman 1999, Ali 
and Kumar 2003), cups with an HA coating did not perform 
better than identical cups without this surface finish (Röhrl 
et al. 2004). This finding is only in partial agreement with a 
large Danish register analysis of HA-coated hip implants that 
found no reduced risk of revision with use of HA-coated cups 
(Paulsen et al. 2007). In that study, the adjusted risk ratio of 
HA-coated cups was calculated to be 0.85 when compared to 
uncoated cups, but with a 95% CI ranging from 0.68 to 1.1. 
One possible reason for this discrepancy could be that a sub-
stantial proportion of the implants investigated in that study 
were Mallory-Head cups, a cup type that was not investigated 
in our study.
The cup design seems to be an important risk factor for 
revision. The Cox regression analysis showed that the Tril-
ogy cup had a statistically significantly better survival than the 
Harris-Galante and the Romanus cups. This finding was not 
unexpected, as inferior results of the Romanus and the Harris-
Galante cups have been reported previously (Thanner et al. 
1999, Lyback et al. 2004, Hallan et al. 2006, Swedish Hip 
Arthroplasty Register 2007). In Harris-Galante cups, exces-
sive liner wear was probably due to an insufficient locking 
mechanism, leading to “silent osteolyses” (Röhrl et al. 2006). 
It has also been described that threaded cups with HA coating 
perform better than some designs of hemispherical press-fit 
cups with HA coating, indicating that differences in fixation 
principles influence cup survival more than HA coating (Reik-
eras and Gunderson 2006). The main problems with the press-
fit cups analyzed in that study were wear and a high frequency 
of thin liners. In our study, the cup size and liner thickness are 
not known, because this was not recorded in the registry data-
base until 1999 and onwards. We do, however, have no reason 
to believe that the size of cups inserted with and without HA 
coating should have varied during the period studied, even if 
this type of bias cannot be completely ruled out. Finally, our 
study only embraced 3 designs. The only one of these still in 
general use does not seem to be significantly affected by the 
use of a ceramic coating (Trilogy).
The association of HA coated cups with stems of inferior 
performance could distort cup survival, as stem revision could 
in some cases have been combined with cup or at least liner 
revision  “en  passant”,  without  actual  cup  loosening  being 
present. Analysis of the various combinations of cup and stem 
components in our study population does not suggest that this 
was the case (Table 6). In the group of Romanus cups coated 
with HA, 60% of patients received an HA-coated Bimetric 
stem. This stem has shown excellent survivorship in other stud-
ies (Lyback et al. 2004, Eskelinen et al. 2006). In the group of 
HA-coated Trilogy cups, the Spectron and Lubinus SPII stems 
represented between 20% and 30% each. None of these stems 
has been reported to show poor survival, and the Link SPII 
stem is considered one of the best-performing cemented stems 
in the registry (Aldinger et al. 2003, Swedish Hip Arthroplasty 
Register 2007). The Spectron EF predominated in the group 
of HA-coated Harris-Galante cups (42%), and this stem has a 
good performance (Swedish Hip Arthroplasty Register 2007).
The degree to which the stem component contributes to cup 
survival is uncertain. In the Cox regression analysis, we found 
that the presence of a cemented stem is a risk factor for cup 
revision due to aseptic loosening when adjusted for all other 
covariates. This indicates that the stem component was an 
independent covariate with influence on outcome, despite the 
fact that the endpoint of our analysis was cup revision, either 
in the presence or absence of stem revision, whereas events 
consisting of stem revision alone were excluded. It should be 
noted that the registered indication for revision surgery was 
“aseptic loosening” of either the cup or both the cup and the 
stem, regardless of the underlying problem. In such cases, a 
revision of the cup or the liner was performed. The cohort of 
8,043 hips we analyzed, with its wide array of different stem 
types and the high number of different cup-and-stem combi-
nations, was not large enough for a comprehensive analysis of 
the factor “type of stem”. Moreover, due to the large number 
of degrees of freedom obtained if individual stem types are 
entered, a Cox regression model including this variable is not 
Table 6. Distribution of stems combined with the cup types Romanus 
(A), Trilogy (B), and Harris-Galante (C)
    + HA  – HA
   n   %   n   %
 
A. Romanus Cup
     Bimetric + HA   262   60   141   13
     Bimetric – HA   67   15   251   23
     Bimetric cemented   15   3   359   33
     Others   96   22   340   31
     440   100   1,091   100
B. Trilogy Cup
     Spectron EF primary   1,215   27   28   3
     Lubinus SPII   1,026   23   70   7
     CLS   942   21   479   46
     Others   1,318   29   458   44
     4,501   100   1,035   100
C. Harris-Galante Cup
     Spectron EF   114   42   172   24
     Lubinus SPII   26   10   245   35
     Charnley   14   5   144   21
     Others   118   43   143   20
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feasible. We could, however, rule out the possibility that HA 
cups were predominantly used in combination with stems of 
inferior performance. 
It has been reported previously that younger patients have 
an inferior outcome after arthroplasty with HA-coated cup 
components (Manley et al. 1998). In this group of patients, hip 
arthroplasty survival is often limited by revision due to oste-
olysis, cup loosening, and/or excessive liner wear (Puolakka et 
al. 1999, Wangen et al. 2008). It could be that the HA coating 
in some designs, due to increased burden of released particles 
from the coating, facilitates these events. Detailed analysis of 
our revision cases including preoperative radiographs would 
be necessary to examine this issue further. 
Several other covariates with a possible influence on cup 
survival were also investigated. The type of hospital at pri-
mary arthroplasty had no statistically significant influence on 
the adjusted risk ratios of the covariates entered in the Cox 
regression model. Some other possible confounding factors 
such as medication with steroids, non-steroidal anti-inflam-
matory drugs, or bisphosphonates that are known to influence 
bone metabolism were not recorded. The same applies to med-
ical conditions that have no known direct effect on implant 
survival, but that could exert an indirect influence, e.g. over-
weight, diabetes mellitus, or lipid metabolism disorders.
We had hypothesized that HA coating would influence cup 
survival, expecting no or beneficial effects. In contrast to these 
expectations, HA coating had a negative effect on cup survival, 
with most marked effects in 1 of the 3 cup designs investigated 
(Romanus). Many of these cups were initially used with femo-
ral heads made of titanium alloy. At the time period for their 
use, this parameter was not recorded. Thus, whether or not 
these heads were used more frequently with HA-coated cups 
is not known. Articulations with different head sizes (22, 28, 
or 32 mm) were used in the study population, but this param-
eter  was  not  systematically  registered  until  1999,  and  was 
therefore not analyzed.
The HA coatings used in the 3 cup designs studied by us 
have shown high biological activity and fixation to bone in 
several studies, where release of calcium ions to the tissues 
close to the implant/bone interface has been regarded as an 
important initiator of bony ingrowth. It could be speculated 
that resorption of the HA coating occurs before secure bone 
ingrowth into the cup surface has been achieved. This could 
lead to inferior stability or loss of bone mineral density (BMD) 
when compared to uncoated cups, where long-lasting bone 
ingrowth can take place. Such loss of BMD has been described 
in the vicinity of HA-coated Trilogy cups (Digas et al. 2006). 
A retrieval analysis of HA-coated cups has shown degrada-
tion of HA in all retrieved cups, and the authors concluded 
that “[…] poor replacement of HA by bone may interfere with 
long-term fixation” (Rokkum et al. 2003). The hypothesis of 
generally  inferior  fixation  of  HA-coated  cups  is,  however, 
contradicted by observations on reduced frequency of radio-
lucent lines around HA-coated cups (Moilanen et al. 1996) 
and a similar BMD around HA-coated and uncoated Trilogy 
or Cambridge cups (Field et al. 2006, Laursen et al. 2007). 
Abrasion of HA particles from the coating has been shown to 
lead to increased wear of the polyethylene liner, thus leading 
to periprosthetic osteolysis and early loosening (Morscher et 
al. 1998). This mechanism may be responsible for the inferior 
survival of HA-coated cups seen in our study.
In  conclusion,  our  results  derived  from  registry  data  on 
8,043 hips indicate that HA coating does not enhance the sur-
vival of cups when using revision for aseptic cup loosening as 
an endpoint. On the contrary, with at least some designs, HA 
coating seems to be a risk factor for cup revision both due to 
aseptic loosening and for any reason, when adjusting for other 
covariates. In contrast, the risk of revision due to deep infec-
tion is not influenced by the type of cup coating. It should be 
emphasized that our study only embraces 3 cup designs that 
are available with or without HA coating. Because numerous 
other cups with pure HA or similar coatings are available on 
the market, further studies of other designs are mandatory. 
Until such information is available, we cannot generally rec-
ommend HA coating of the acetabular component in primary 
arthroplasty. The extra economic burden of HA coating added 
onto the surface of these cups does not seem to be justified.
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